packageAlpelisib

alpelisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Alpelisib is a cancer medicine used to treat breast cancer. It is an approved drug authorised in the European Union, where it is also being studied for certain genetic growth disorders.

Summary written by glm-5.3-flash from Wikidata Q27074391 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:alpelisib
ATC codes:L01EM03, L01XE
DrugBank:DB12015
PubChem CID:56649450
ChEBI:93752
Wikidata:Q27074391
formula:C19H22F3N5O2S
molar mass:441.472 g/mol (PubChem CID 56649450)
logP:3.2 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown